5:15 PM
 | 
Oct 08, 2007
 |  BC Extra  |  Top Story

GSK names Witty CEO

GlaxoSmithKline (LSE:GSK; GSK) will promote Andrew Witty to CEO from president of pharmaceuticals Europe, effective May 2008. He will replace Jean-Pierre Garnier, who will retire. Separately,

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >